6535
順藥
-0.60 (-0.80%)74.60140成交張數–本益比10.18股價淨值比0.00%殖利率2026-09-16資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入 · 未來期間為分析師共識預估(2026-09-09)
營業收入202536年增 -8.5%
毛利率202561.0%最新一期
營業利益率2025-930.7%最新一期
每股盈餘2025-2.05
| 會計項目 | 走勢 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 預估 1 家 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業收入合計 | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 營業成本合計 | 19.6% | 29.0% | 24.4% | 16.6% | 39.2% | 43.0% | 45.3% | 27.1% | 54.8% | 39.0% | – | |
| 營業毛利（毛損） | 80.4% | 71.0% | 75.6% | 83.4% | 60.8% | 57.0% | 54.7% | 72.9% | 45.2% | 61.0% | 93.3% | |
| 營業毛利（毛損）淨額 | 80.4% | 71.0% | 75.6% | 83.4% | 60.8% | 57.0% | 54.7% | 72.9% | 45.2% | 61.0% | – | |
| 營業費用合計 | 2226.4% | 625.6% | 303.4% | 170.5% | 1638.3% | 2535.2% | 1202.9% | 733.1% | 957.3% | 991.8% | – | |
| 營業利益（損失） | -2145.9% | -554.6% | -227.8% | -87.2% | -1577.5% | -2478.3% | -1148.3% | -660.2% | -912.1% | -930.7% | -102.3% | |
| 稅前淨利（淨損） | -1842.4% | -603.7% | -83.1% | -131.5% | -1489.8% | 552.6% | -1893.4% | -439.4% | -1115.7% | -967.4% | – | |
| 所得稅費用（利益）合計 | – | – | – | 8.5% | 0.0% | 0.0% | 0.1% | 0.4% | 0.0% | 0.0% | – | |
| 繼續營業單位本期淨利（淨損） | -1842.4% | -603.7% | -83.1% | -140.0% | -1489.8% | 552.6% | -1893.6% | -439.8% | -1115.7% | -967.4% | – | |
| 本期淨利（淨損） | -1842.4% | -603.7% | -83.1% | -140.0% | -1489.8% | 552.6% | -1893.6% | -439.8% | -1115.7% | -967.4% | – | |
| 本期綜合損益總額 | -1938.5% | -563.2% | -89.5% | -140.0% | -1489.8% | 552.6% | -1893.5% | -439.9% | -1115.6% | -967.4% | – | |
| 母公司業主（淨利∕損） | -1842.4% | -603.7% | -83.1% | -140.0% | -1489.8% | 552.6% | -1856.7% | -418.2% | -1084.9% | -950.4% | -101.1% | |
| 基本每股盈餘 | -21.2% | -6.4% | -0.8% | -1.2% | -12.3% | 3.7% | -11.4% | -2.6% | -6.6% | -5.7% | -0.6% |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。最右邊的預估欄是分析師共識預估(2026-09-09),營收、營業利益、母公司淨利、每股盈餘直接取共識平均,毛利由共識營收乘上共識毛利率推算,不是公司財測。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。